Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.

Liccioli G, Mori F, Parronchi P, Capone M, Fili L, Barni S, Sarti L, Giovannini M, Resti M, Novembre EM.

Clin Exp Allergy. 2019 Oct 13. doi: 10.1111/cea.13513. [Epub ahead of print]

PMID:
31608511
2.

Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine.

Martinez-Prat L, Palterer B, Vitiello G, Parronchi P, Robinson WH, Mahler M.

Expert Rev Clin Immunol. 2019 Oct;15(10):1073-1087. doi: 10.1080/1744666X.2020.1668778. Epub 2019 Oct 13.

PMID:
31524005
3.

Gender differences in anaphylaxis.

Salvati L, Vitiello G, Parronchi P.

Curr Opin Allergy Clin Immunol. 2019 Oct;19(5):417-424. doi: 10.1097/ACI.0000000000000568.

PMID:
31465313
4.

The multiple roles of mite allergens in allergic diseases.

Vitiello G, Biagioni B, Parronchi P.

Curr Opin Allergy Clin Immunol. 2019 Dec;19(6):623-631. doi: 10.1097/ACI.0000000000000573.

PMID:
31369416
5.

Intravenous immunoglobulin therapy: a snapshot for the internist.

Vitiello G, Emmi G, Silvestri E, Di Scala G, Palterer B, Parronchi P.

Intern Emerg Med. 2019 Oct;14(7):1041-1049. doi: 10.1007/s11739-019-02150-z. Epub 2019 Jul 15. Review.

PMID:
31309519
6.

Migrants and allergy: a new view of the atopic march.

Biagioni B, Vitiello G, Bormioli S, Tarrini D, Lombardi C, Rossi O, Parronchi P.

Eur Ann Allergy Clin Immunol. 2019 May 13;51(3):100-114. doi: 10.23822/EurAnnACI.1764-1489.96. Epub 2019 Apr 15. Review.

7.

Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment.

Emmi G, Bettiol A, Palterer B, Silvestri E, Vitiello G, Parronchi P, Prisco D.

Autoimmun Rev. 2019 Mar;18(3):312-314. doi: 10.1016/j.autrev.2018.11.002. Epub 2019 Jan 11. No abstract available.

PMID:
30639638
8.

The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment.

Matucci A, Nencini F, Rossi O, Pratesi S, Parronchi P, Maggi E, Vultaggio A.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):339-340. doi: 10.1016/j.jaip.2018.06.011. Epub 2018 Jul 2. No abstract available.

PMID:
30599882
9.

Amoxicillin/clavulanic acid-induced exfoliative dermatitis in a child.

Barni S, Mori F, Fili L, Parronchi P, Novembre E.

Minerva Pediatr. 2018 Oct;70(5):495-496. doi: 10.23736/S0026-4946.17.04845-9. No abstract available.

PMID:
30302990
10.

Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FcεRI.

Maggi L, Rossettini B, Montaini G, Matucci A, Vultaggio A, Mazzoni A, Palterer B, Parronchi P, Maggi E, Liotta F, Annunziato F, Cosmi L.

Eur J Immunol. 2018 Dec;48(12):2005-2014. doi: 10.1002/eji.201847668. Epub 2018 Oct 9.

PMID:
30252930
11.

Sensitization to amoxicillin/clavulanic acid may underlie severe rashes in children treated for infectious mononucleosis.

Mori F, Fili L, Barni S, Giovannini M, Capone M, Novembre EM, Parronchi P.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):728-731.e1. doi: 10.1016/j.jaip.2018.06.022. Epub 2018 Aug 16. No abstract available.

PMID:
30009989
12.

Therapeutic Efficacy of Autologous Non-Mobilized Enriched Circulating Endothelial Progenitors in Patients With Critical Limb Ischemia - The SCELTA Trial.

Liotta F, Annunziato F, Castellani S, Boddi M, Alterini B, Castellini G, Mazzanti B, Cosmi L, Acquafresca M, Bartalesi F, Dilaghi B, Dorigo W, Graziani G, Bartolozzi B, Bellandi G, Carli G, Bartoloni A, Fargion A, Fassio F, Fontanari P, Landini G, Lucente EAM, Michelagnoli S, Orsi Battaglini C, Panigada G, Pigozzi C, Querci V, Santarlasci V, Parronchi P, Troisi N, Baggiore C, Romagnani P, Mannucci E, Saccardi R, Pratesi C, Gensini G, Romagnani S, Maggi E.

Circ J. 2018 May 25;82(6):1688-1698. doi: 10.1253/circj.CJ-17-0720. Epub 2018 Mar 23.

13.

Bench to bedside review of myositis autoantibodies.

Palterer B, Vitiello G, Carraresi A, Giudizi MG, Cammelli D, Parronchi P.

Clin Mol Allergy. 2018 Mar 7;16:5. doi: 10.1186/s12948-018-0084-9. eCollection 2018. Review.

14.

Identification of T-cell epitopes from benzylpenicillin conjugated to human serum albumin and implication in penicillin allergy.

Azoury ME, Filì L, Bechara R, Scornet N, de Chaisemartin L, Weaver RJ, Claude N, Maillere B, Parronchi P, Joseph D, Pallardy M.

Allergy. 2018 Aug;73(8):1662-1672. doi: 10.1111/all.13418. Epub 2018 Feb 27.

PMID:
29355985
15.

Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.

Vitiello G, Orsi Battaglini C, Carli G, Radice A, Matucci A, Vultaggio A, Olianti C, Parronchi P, Maggi E, Cammelli D.

Angiology. 2018 Oct;69(9):763-769. doi: 10.1177/0003319717753223. Epub 2018 Jan 17.

PMID:
29343075
16.

Neuromyelitis optica, atypical hemophagocytic lymphohistiocytosis and heterozygous perforin A91V mutation.

Palterer B, Brugnolo F, Sieni E, Barilaro A, Parronchi P.

J Neuroimmunol. 2017 Oct 15;311:10-13. doi: 10.1016/j.jneuroim.2017.08.003. Epub 2017 Aug 15.

PMID:
28863861
17.

T-cell activation in two cases of Stevens-Johnson syndrome after receiving amoxicillin-clavulanic acid.

Mori F, Fili L, Barni S, Sarti L, Montemaggi A, Bassi A, Filippeschi C, Galli L, Parronchi P, Novembre E.

Pediatr Allergy Immunol. 2017 Sep;28(6):602-606. doi: 10.1111/pai.12741. No abstract available.

PMID:
28599076
18.

Miescher's cheilitis: Surgical management and long term outcome of an extremely severe case.

Innocenti A, Innocenti M, Taverna C, Melita D, Mori F, Ciancio F, De Giorgi V, Parronchi P, Vultaggio A, Matucci A.

Int J Surg Case Rep. 2017;31:241-244. doi: 10.1016/j.ijscr.2017.01.062. Epub 2017 Jan 30.

19.

How pregnancy can affect autoimmune diseases progression?

Piccinni MP, Lombardelli L, Logiodice F, Kullolli O, Parronchi P, Romagnani S.

Clin Mol Allergy. 2016 Sep 15;14:11. doi: 10.1186/s12948-016-0048-x. eCollection 2016. Review.

20.

Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity.

Pratesi S, Nencini F, Filì L, Occhiato EG, Romagnani S, Parronchi P, Maggi E, Vultaggio A.

Mol Immunol. 2016 Sep;77:60-70. doi: 10.1016/j.molimm.2016.07.011. Epub 2016 Jul 29.

PMID:
27475304
21.

Tocilizumab-induced mucosal ulcers in a patient with relapsing polychondritis: An adverse drug reaction?

Vitiello G, Palterer B, Parronchi P, Cammelli D.

Semin Arthritis Rheum. 2016 Oct;46(2):e9-e10. doi: 10.1016/j.semarthrit.2016.03.016. Epub 2016 Apr 1. No abstract available.

PMID:
27139166
22.

Drug fever after a single dose of amoxicillin-clavulanic acid.

Mori F, Fili L, Barni S, Sarti L, Pucci N, Parronchi P, Novembre E.

J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):533-534.e1. doi: 10.1016/j.jaip.2015.11.030. Epub 2015 Dec 24. No abstract available.

PMID:
26725154
23.

MDA5-positive dermatomyositis: an uncommon entity in Europe with variable clinical presentations.

Parronchi P, Radice A, Palterer B, Liotta F, Scaletti C.

Clin Mol Allergy. 2015 Nov 9;13:22. doi: 10.1186/s12948-015-0031-y. eCollection 2015. Review.

24.

Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation.

Nencini F, Pratesi S, Petroni G, Filì L, Cardilicchia E, Casini A, Occhiato EG, Calosi L, Bani D, Romagnani S, Maggi E, Parronchi P, Vultaggio A.

Immunology. 2015 Aug;145(4):570-82. doi: 10.1111/imm.12475. Epub 2015 Jun 8.

25.

A rare condition: IgE type monoclonal gammopathy of undetermined significance.

Caldini A, Balboni F, Parronchi P, Scoccianti S, Biagioli T, Terreni A, Morrocchi B, Brogi M, Berardi M, Graziani M.

Clin Chem Lab Med. 2014 Aug;52(8):e183-5. doi: 10.1515/cclm-2014-0182. No abstract available.

PMID:
24791823
26.

Hapten-specific TH17 cells in the peripheral blood of β-lactam-induced AGEP.

Filì L, Cardilicchia E, Severino MG, Testi S, Matucci A, Vultaggio A, Paglierani M, Massi D, Maggi E, Parronchi P.

Allergol Int. 2014 Mar;63(1):129-31. doi: 10.2332/allergolint.13-LE-0582. Epub 2013 Dec 25. No abstract available.

27.

Perspectives in vaccine adjuvants for allergen-specific immunotherapy.

Filì L, Cardilicchia E, Maggi E, Parronchi P.

Immunol Lett. 2014 Oct;161(2):207-10. doi: 10.1016/j.imlet.2013.12.011. Epub 2013 Dec 19. Review.

PMID:
24361819
28.

A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy.

Filì L, Vultaggio A, Cardilicchia E, Manuelli C, Casini A, Nencini F, Maggi L, Pratesi S, Petroni G, Boscaro F, Guarna A, Occhiato EG, Romagnani S, Maggi E, Parronchi P.

J Allergy Clin Immunol. 2013 Jul;132(1):84-92. doi: 10.1016/j.jaci.2013.01.030. Epub 2013 Mar 14.

PMID:
23498597
29.

The management of paediatric allergy: not everybody's cup of tea--10-11th February 2012.

Fiocchi A, Annunziato F, Assa'ad A, Arshad H, Bahna SL, Boyle R, Brozek J, Bush A, Canonica W, Cicardi M, Compalati E, Dahdah L, Dupont C, Finegold I, Fineman SM, Grabenhenrich L, Holgate S, Kuitunen M, Lau S, Maggi E, Martelli A, Matricardi P, Moretta L, Palmer D, Parronchi P, Pawankar R, Prescott S, Restani P, Rosenwasser L, Terracciano L, Scheurer S, Tripodi S, Vieths S, Von Berg A, Vultaggio A, Weber RW.

Curr Opin Allergy Clin Immunol. 2013 Mar;13 Suppl 1:S1-50. doi: 10.1097/ACI.0b013e32835e8b94. No abstract available.

PMID:
23377496
30.

Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.

Antiga E, Volpi W, Cardilicchia E, Maggi L, Filì L, Manuelli C, Parronchi P, Fabbri P, Caproni M.

J Clin Immunol. 2012 Dec;32(6):1221-32. doi: 10.1007/s10875-012-9716-x. Epub 2012 Jun 15.

PMID:
22699761
31.

The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines.

Vultaggio A, Nencini F, Pratesi S, Maggi L, Guarna A, Annunziato F, Romagnani S, Parronchi P, Maggi E.

J Immunol. 2011 Apr 15;186(8):4707-15. doi: 10.4049/jimmunol.1002398. Epub 2011 Mar 9.

32.

Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4.

Cosmi L, Maggi L, Santarlasci V, Capone M, Cardilicchia E, Frosali F, Querci V, Angeli R, Matucci A, Fambrini M, Liotta F, Parronchi P, Maggi E, Romagnani S, Annunziato F.

J Allergy Clin Immunol. 2010 Jan;125(1):222-30.e1-4. doi: 10.1016/j.jaci.2009.10.012.

PMID:
20109749
33.

Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions.

Vultaggio A, Matucci A, Nencini F, Pratesi S, Parronchi P, Rossi O, Romagnani S, Maggi E.

Allergy. 2010 May;65(5):657-61. doi: 10.1111/j.1398-9995.2009.02280.x. Epub 2009 Nov 27.

PMID:
19951375
34.

Influence of total serum IgE levels on the in vitro detection of beta-lactams-specific IgE antibodies.

Vultaggio A, Matucci A, Virgili G, Rossi O, Filì L, Parronchi P, Romagnani S, Maggi E.

Clin Exp Allergy. 2009 Jun;39(6):838-44. doi: 10.1111/j.1365-2222.2009.03219.x. Epub 2009 Apr 7.

PMID:
19400911
35.

Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7.

Vultaggio A, Nencini F, Fitch PM, Filì L, Maggi L, Fanti P, deVries A, Beccastrini E, Palandri F, Manuelli C, Bani D, Giudizi MG, Guarna A, Annunziato F, Romagnani S, Maggi E, Howie SE, Parronchi P.

J Immunol. 2009 Jan 15;182(2):880-9.

36.

Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor.

Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, Rodolico G, Querci V, Abbate G, Angeli R, Berrino L, Fambrini M, Caproni M, Tonelli F, Lazzeri E, Parronchi P, Liotta F, Maggi E, Romagnani S, Annunziato F.

J Exp Med. 2008 Aug 4;205(8):1903-16. doi: 10.1084/jem.20080397. Epub 2008 Jul 28.

37.

Safety and tolerability of infliximab therapy: suggestions and criticisms based on wide clinical experience.

Vultaggio A, Matucci A, Parronchi P, Rossi O, Palandri F, Romagnani S, Maggi E.

Int J Immunopathol Pharmacol. 2008 Apr-Jun;21(2):367-74.

PMID:
18547481
38.

Association between "sarcoidosis-like" disease and common variable immunodeficiency (CVI): a new CVI variant showing an activation of the immune system.

Vultaggio A, Matucci A, Parronchi P, Rossi O, Filì L, Giudizi MG, Palandri F, Agostini C, Semenzato G, Romagnani S, Maggi E.

Sarcoidosis Vasc Diffuse Lung Dis. 2007 Sep;24(2):127-33.

PMID:
18496983
39.

Human immature myeloid dendritic cells trigger a TH2-polarizing program via Jagged-1/Notch interaction.

Liotta F, Frosali F, Querci V, Mantei A, Filì L, Maggi L, Mazzinghi B, Angeli R, Ronconi E, Santarlasci V, Biagioli T, Lasagni L, Ballerini C, Parronchi P, Scheffold A, Cosmi L, Maggi E, Romagnani S, Annunziato F.

J Allergy Clin Immunol. 2008 Apr;121(4):1000-5.e8. doi: 10.1016/j.jaci.2008.01.004. Epub 2008 Mar 4.

PMID:
18313135
40.

Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.

Liotta F, Angeli R, Cosmi L, Filì L, Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V, Santarlasci V, Consoloni L, Angelotti ML, Romagnani P, Parronchi P, Krampera M, Maggi E, Romagnani S, Annunziato F.

Stem Cells. 2008 Jan;26(1):279-89. Epub 2007 Oct 25.

41.

Phenotypic and functional features of human Th17 cells.

Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Filì L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S.

J Exp Med. 2007 Aug 6;204(8):1849-61. Epub 2007 Jul 16.

42.

High intracytoplasmatic levels of Il-4 and Il-5 in a patient with Gleichs syndrome: case report.

Novembre E, Mori F, Arcangeli F, Cianferoni A, Bernardini R, Pucci N, Annunziato F, Parronchi P, De Martino M, Vierucci A.

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):935-8.

PMID:
17166416
43.

Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release.

Filì L, Ferri S, Guarna F, Sampognaro S, Manuelli C, Liotta F, Cosmi L, Matucci A, Vultaggio A, Annunziato F, Maggi E, Guarna A, Romagnani S, Parronchi P.

J Allergy Clin Immunol. 2006 Aug;118(2):511-7.

PMID:
16890779
44.

Tako-Tsubo-like syndrome during anaphylactic reaction.

Vultaggio A, Matucci A, Del Pace S, Simonetti I, Parronchi P, Rossi O, Maggi E, Gensini G, Romagnani S.

Eur J Heart Fail. 2007 Feb;9(2):209-11. Epub 2006 Jul 7.

45.

CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production.

Romagnani P, Maggi L, Mazzinghi B, Cosmi L, Lasagni L, Liotta F, Lazzeri E, Angeli R, Rotondi M, Filì L, Parronchi P, Serio M, Maggi E, Romagnani S, Annunziato F.

J Allergy Clin Immunol. 2005 Dec;116(6):1372-9.

PMID:
16337473
46.

Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients.

Matucci A, Parronchi P, Vultaggio A, Rossi O, Brugnolo F, Maggi E, Romagnani S.

Allergy. 2004 Oct;59(10):1133-4. No abstract available.

PMID:
15355480
47.

The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.

Brugnolo F, Sampognaro S, Liotta F, Cosmi L, Annunziato F, Manuelli C, Campi P, Maggi E, Romagnani S, Parronchi P.

J Allergy Clin Immunol. 2003 Feb;111(2):380-8.

PMID:
12589360
48.

Coronary vasospasm during an acute allergic reaction.

Matucci, Rossi O, Cecchi L, Vultaggio A, Parronchi P, Brugnolo F, Maggi E, Romagnani S.

Allergy. 2002 Sep;57(9):867-8. No abstract available.

PMID:
12169196
49.

["Sarcoidosis-like" granulomatous disease in patients with common variable hypogammaglobulinemia].

Matucci A, Rossi O, Cecchi L, Vultaggio A, Checcacci S, Parronchi P, Emmi L, Maggi E, Romagnani S.

Ann Ital Med Int. 2002 Apr-Jun;17(2):108-16. Italian.

PMID:
12150044
50.

Role of low nuclear grading of renal carcinoma cells in the functional profile of tumor-infiltrating T cells.

Puccetti L, Manetti R, Parronchi P, Piccinni MP, Mavilia C, Carini M, Romagnani S, Maggi E.

Int J Cancer. 2002 Apr 10;98(5):674-81.

Supplemental Content

Loading ...
Support Center